| ESHRE consensus on the definition of ‘poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria AP Ferraretti, A La Marca, B Fauser, B Tarlatzis, G Nargund, L Gianaroli, ... Human reproduction 26 (7), 1616-1624, 2011 | 2229 | 2011 |
| Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) A La Marca, G Sighinolfi, D Radi, C Argento, E Baraldi, AC Artenisio, ... Human reproduction update 16 (2), 113-130, 2010 | 1238 | 2010 |
| The physiology and clinical utility of anti-Müllerian hormone in women D Dewailly, CY Andersen, A Balen, F Broekmans, N Dilaver, R Fanchin, ... Human reproduction update 20 (3), 370-385, 2014 | 1228 | 2014 |
| Serum anti-Mullerian hormone throughout the human menstrual cycle A La Marca, G Stabile, AC Artenisio, A Volpe Human reproduction 21 (12), 3103-3107, 2006 | 768 | 2006 |
| Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice A La Marca, SK Sunkara Human reproduction update 20 (1), 124-140, 2014 | 712 | 2014 |
| Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach SL Broer, J van Disseldorp, KA Broeze, M Dolleman, BC Opmeer, ... Human reproduction update 19 (1), 26-36, 2013 | 543 | 2013 |
| Anti‐Müllerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool? A La Marca, A Volpe Clinical endocrinology 64 (6), 603-610, 2006 | 476 | 2006 |
| Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology A La Marca, S Giulini, A Tirelli, E Bertucci, T Marsella, S Xella, A Volpe Human reproduction 22 (3), 766-771, 2007 | 464 | 2007 |
| Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays A La Marca, M Capuzzo, T Paglia, L Roli, T Trenti, SM Nelson Reproductive biomedicine online 41 (3), 483-499, 2020 | 454 | 2020 |
| Anti-Müllerian hormone (AMH): what do we still need to know? A La Marca, FJ Broekmans, A Volpe, BC Fauser, NS Macklon Human reproduction 24 (9), 2264-2275, 2009 | 454 | 2009 |
| Insulin-lowering agents in the management of polycystic ovary syndrome V De Leo, A La Marca, F Petraglia Endocrine reviews 24 (5), 633-667, 2003 | 448 | 2003 |
| Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome V De Leo, A La Marca, A Ditto, G Morgante, A Cianci Fertility and sterility 72 (2), 282-285, 1999 | 350 | 1999 |
| Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality B Baccetti, A La Marca, P Piomboni, S Capitani, E Bruni, F Petraglia, ... Human Reproduction 17 (10), 2673-2677, 2002 | 335 | 2002 |
| LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling L Casarini, M Lispi, S Longobardi, F Milosa, A La Marca, D Tagliasacchi, ... Public Library of Science 7 (10), e46682, 2012 | 294 | 2012 |
| ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’to ovarian stimulation for in vitro fertilization: the Bologna criteria AP Ferraretti, A La Marca, BC Fauser, B Tarlatzis, G Nargund, L Gianaroli Hum Reprod 26 (7), 1616-1624, 2011 | 277 | 2011 |
| ESHRE guideline: ovarian stimulation for IVF/ICSI† ESHRE Guideline Group on Ovarian Stimulation, E Bosch, S Broer, ... Human reproduction open 2020 (2), hoaa009, 2020 | 251 | 2020 |
| Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial A Nyboe Andersen, SM Nelson, BCJM Fauser, JA García-Velasco, ... Fertility and Sterility 107 (2), 387-396. e4, 2017 | 251 | 2017 |
| Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation A La Marca, S Malmusi, S Giulini, LF Tamaro, R Orvieto, P Levratti, ... Human Reproduction 19 (12), 2738-2741, 2004 | 250 | 2004 |
| Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients JC Arce, A La Marca, BM Klein, AN Andersen, R Fleming Fertility and sterility 99 (6), 1644-1653. e1, 2013 | 238 | 2013 |
| Hormonal effects of flutamide in young women with polycystic ovary syndrome V De Leo, D Lanzetta, D D’Antona, A La Marca, G Morgante The Journal of Clinical Endocrinology & Metabolism 83 (1), 99-102, 1998 | 232 | 1998 |
